SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Bolsa de Comercio de Buenos Aires
Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Börse Frankfurt
    ISIN US4781601046
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse Stuttgart
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse München
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse Berlin
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Xetra Frankfurt
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Gettex System der Börse München
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Quotrix System der Börse Düsseldorf
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Börse Düsseldorf
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Börse Hamburg
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse SGO
    USD
  • Johnson & Johnson
    Börse BUE
    USD
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
  • Johnson & Johnson
    Börse SSE
Marktkapitalisierung 99.567.000.000
Mitarbeiter 141.700

Analystenmeinungen

Übersicht

Aktionärsstruktur der Johnson & Johnson

3.033 News & Informationen zur Johnson & Johnson Aktie

  • Global $400+ Mn Dry Eye Treatment Devices Market to 2028 Featuring Lumenis; ESW Vision; Johnson & Johnson; MiBo Medical; Alcon; and Sight...
    prnewswire.com

    Global $400+ Mn Dry Eye Treatment Devices Market to 2028 Featuring Lumenis; ESW Vision; Johnson & Johnson; MiBo Medical; Alcon; and Sight Sciences

    /PRNewswire/ — The

  • Global $400 Mn Dry Eye Treatment Devices Market To 2028 Featuring Lumenis; ESW Vision; Johnson & Johnson; MiBo Medical; Alcon; And Sight...
    thestreet.com

    Global $400 Mn Dry Eye Treatment Devices Market To 2028 Featuring Lumenis; ESW Vision; Johnson & Johnson; MiBo Medical; Alcon; And Sight Sciences

    DUBLIN, Sept. 17, 2021 /PRNewswire/ — The

  • Trinity Biotech : This report has been prepared in accordance with the Irish Companies Act 2014 (Form 6-K)
    marketscreener.com

    Trinity Biotech : This report has been prepared in accordance with the Irish Companies Act 2014 (Form 6-K)

    continuing operations

    12

    … | September 17, 2021

  • The FDA's expert panel backs COVID-19 booster shots for adults 65+ and those at highest risk of severe disease
    businessinsider.com

    The FDA's expert panel backs COVID-19 booster shots for adults 65+ and those at highest risk of severe disease

    A panel of experts recommended booster shots, but only for older adults and others who are at the greatest risk from the pandemic.

  • FDA committee votes against approving BioNTech and Pfizer’s COVID-19 booster
    marketwatch.com

    FDA committee votes against approving BioNTech and Pfizer’s COVID-19 booster

    A group of advisors to the Food and Drug Administration said the regulator should not allow Americans to get a booster dose of BioNTech SE and Pfizer Inc.'s…

  • 3 Popular Robinhood Stocks to Add to Your Portfolio This Month By StockNews
    investing.com

    3 Popular Robinhood Stocks to Add to Your Portfolio This Month By StockNews

    3 Popular Robinhood Stocks to Add to Your Portfolio This Month

  • LATINA Style Inc. Announces the 2021 LATINA Style 50 Report
    prnewswire.com

    LATINA Style Inc. Announces the 2021 LATINA Style 50 Report

    /PRNewswire/ — LATINA Style Inc., the premier company addressing the needs of Latina professionals and business owners in the U.S., announces the LATINA Style…

  • Osso VR CEO Justin Barad on VatorNews podcast
    vator.tv

    Osso VR CEO Justin Barad on VatorNews podcast

    Osso VR CEO Justin Barad on VatorNews podcast. Osso is a platform that allows surgeons to practice their skills in a virtual environment by Steven Loeb on September 17, 2021

  • Worldwide Short Bowel Syndrome Industry to 2026 - Development of Short Bowel Syndrome Drugs is at a Nascent Stage Presents Opportunities
    prnewswire.com

    Worldwide Short Bowel Syndrome Industry to 2026 – Development of Short Bowel Syndrome Drugs is at a Nascent Stage Presents Opportunities

    /PRNewswire/ — The “Short Bowel Syndrome Market Research Report by Drug Class (GLP-2, Glutamine, and Growth Hormone), by Region (Americas, Asia-Pacific, and…

  • Global Industry Analysts Predicts the World Natural and Organic Skin Care Products Market to Reach $9.7 Billion by 2026
    prnewswire.com

    Global Industry Analysts Predicts the World Natural and Organic Skin Care Products Market to Reach $9.7 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Shake Shack, Marriott, and other top companies are facing a painful labor shortage. Here's what executives are saying about the problem.
    markets.businessinsider.com

    Shake Shack, Marriott, and other top companies are facing a painful labor shortage. Here's what executives are saying about the problem.

    Shake Shack workers. Shake Shack Many US companies are struggling to hire workers due to a widespread labor shortage. Shake Shack, Marriott, J…

  • Global Immunology Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021
    prnewswire.com

    Global Immunology Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021

    /PRNewswire/ — Gain comprehensive access to over 850 immunology deal records from this report “Global Immunology Partnering 2014-2021: Deal Trends, Players…

  • FDA’s Vaccine Advisory Committee Weighs Necessity Of Pfizer Covid Booster Shots
    forbes.com

    FDA’s Vaccine Advisory Committee Weighs Necessity Of Pfizer Covid Booster Shots

    The panel, which informs the FDA’s decisions on vaccine approval, is set to make its recommendation on Friday.

  • +++Coronavirus-Update+++ - Corona - Bundesrat verschärft ab Montag Einreiseregeln in die Schweiz - Ungeimpfte müssen sich bei Rückkehr...
    cash.ch

    +++Coronavirus-Update+++ – Corona – Bundesrat verschärft ab Montag Einreiseregeln in die Schweiz – Ungeimpfte müssen sich bei Rückkehr zweimal testen – Einreiseformular-Pflicht für alle – BAG registri

    Erfahren Sie hier alle aktuellen Entwicklungen zur Coronavirus-Krise, zusammengetragen von der Redaktion von cash.ch.

  • Indemnity issues may hold up availability of J&J single dose vaccine
    economictimes.indiatimes.com

    Indemnity issues may hold up availability of J&J single dose vaccine

    While the drug regulator has given a nod to Biological E to manufacture the vaccine at its plant in Telangana, its launch looks unlikely till the government resolves the indemnity issue. “The discussions between the government and the company are ongoing and there is no conclusion yet on the indemnity issue,” said a senior government official on the condition of anonymity.

  • Analysts Are Downgrading These 10 Stocks
    insidermonkey.com

    Analysts Are Downgrading These 10 Stocks

    The post-pandemic economic recovery has hit roadblocks in the past few days as new unemployment data pours in, major Wall Street indexes register small dips, and Chinese authorities extend a regulatory…

  • Johnson & Johnson presents trial data for BALVERSA plus cetrelimab in bladder cancer
    seekingalpha.com

    Johnson & Johnson presents trial data for BALVERSA plus cetrelimab in bladder cancer

    The Janssen Pharmaceutical of Johnson & Johnson (JNJ) has disclosed results from a Phase 1b/2 study designed to evaluate BALVERSA (erdafitinib) plus cetrelimab versus BALVERSA alone…

  • The New York Times' 'The Morning' newsletter has grown to more than 5 million daily readers and has become one of the paper's most...
    markets.businessinsider.com

    The New York Times' 'The Morning' newsletter has grown to more than 5 million daily readers and has become one of the paper's most influential properties. Now it plans to expand even further.

    David Leonhardt, the author of

  • +++Coronavirus-Update+++ - Corona: BAG registriert 2095 neue Coronavirus-Fälle und 51 Spitaleinweisungen in der Schweiz - Bundesrat...
    cash.ch

    +++Coronavirus-Update+++ – Corona: BAG registriert 2095 neue Coronavirus-Fälle und 51 Spitaleinweisungen in der Schweiz – Bundesrat informiert um 15 Uhr über Reiseregeln in den Herbstferien – In Deuts

    Erfahren Sie hier alle aktuellen Entwicklungen zur Coronavirus-Krise, zusammengetragen von der Redaktion von cash.ch.

  • +++Coronavirus-Update+++ - Corona: Bundesrat informiert um 15 Uhr über Reiseregeln in den Herbstferien - Schwierige Wintermonate, aber...
    cash.ch

    +++Coronavirus-Update+++ – Corona: Bundesrat informiert um 15 Uhr über Reiseregeln in den Herbstferien – Schwierige Wintermonate, aber Pandemie in der Schweiz «im Frühling vorbei» – In Deutschland sin

    Erfahren Sie hier alle aktuellen Entwicklungen zur Coronavirus-Krise, zusammengetragen von der Redaktion von cash.ch.

  • Pharma - Gehäufte Corona-Impfdurchbrüche bei Johnson & Johnson - was steckt dahinter?
    cash.ch

    Pharma – Gehäufte Corona-Impfdurchbrüche bei Johnson & Johnson – was steckt dahinter?

    Geimpft und trotzdem an Corona erkrankt? Das ist zwar selten, trotzdem kommt es vor. Auffällig hoch ist die Zahl sogenannter Impfdurchbrüche beim Impfstoff von Johnson & Johnson.

  • COVID-19 Task Force Issues FAQs on Vaccine Mandate for Federal Workers
    shrm.org

    COVID-19 Task Force Issues FAQs on Vaccine Mandate for Federal Workers

    Federal employees—including remote workers—will need to be fully vaccinated against the coronavirus by Nov. 22, according to recently released FAQs from the Safer Federal Workforce Task Force.

  • Mat Bisher Joins DDB New York as Chief Creative Officer, Further Fueling the Power of Creativity within the New York Office
    markets.businessinsider.com

    Mat Bisher Joins DDB New York as Chief Creative Officer, Further Fueling the Power of Creativity within the New York Office

    NEW YORK, Sept. 16, 2021 /PRNewswire/ — DDB has announced the appointment of Mat Bisher to Chief Creative Officer, DDB NY to lead creative teams …

  • Mat Bisher Joins DDB New York as Chief Creative Officer, Further Fueling the Power of Creativity within the New York Office
    prnewswire.com

    Mat Bisher Joins DDB New York as Chief Creative Officer, Further Fueling the Power of Creativity within the New York Office

    /PRNewswire/ — DDB has announced the appointment of Mat Bisher to Chief Creative Officer, DDB NY to lead creative teams at the network's flagship office….

  • Kelantan allows 40 congregants for Friday, obligatory prayers from today
    thesundaily.my

    Kelantan allows 40 congregants for Friday, obligatory prayers from today

    KOTA BHARU: The Kelantan Islamic Religious and Malay Customs Council (Maik) has given the green light for Friday and obligatory prayers at all distric…

  • Vaccinated Mr President? We'll take your word for it, U.N. says By Reuters
    investing.com

    Vaccinated Mr President? We'll take your word for it, U.N. says By Reuters

    Vaccinated Mr President? We'll take your word for it, U.N. says

  • Johnson & Johnson : to Host Investor Conference Call on Third-Quarter Results
    marketscreener.com

    Johnson & Johnson : to Host Investor Conference Call on Third-Quarter Results

    NEW BRUNSWICK, N.J. , Sept. 16, 2021 /PRNewswire/ — Johnson & Johnson will host a conference call for investors at 8:30 a.m. on Tuesday, October 19th to review third-quarter results…. | September 16, 2021

  • Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
    prnewswire.com

    Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

    /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 19th to review…

  • Johnson & Johnson (JNJ) Stock Moves -0.12%: What You Should Know
    zacks.com

    Johnson & Johnson (JNJ) Stock Moves -0.12%: What You Should Know

    Johnson & Johnson (JNJ) closed at $165.22 in the latest trading session, marking a -0.12% move from the prior day.

  • Vaccine Stocks: Why The FDA Is Likely To Sign Off On Boosters — With Some Caveats
    investors.com

    Vaccine Stocks: Why The FDA Is Likely To Sign Off On Boosters — With Some Caveats

    Booster shots could expand the opportunity for Covid vaccine stocks like Pfizer and Moderna by $3 billion to $4 billion in the U.S. alone.

  • Biden vaccine mandate: Small business advocacy group prepares to sue administration
    news.google.com

    Biden vaccine mandate: Small business advocacy group prepares to sue administration

    FIRST ON FOX: A conservative, small business advocacy group is preparing to sue the Biden administration over its coronavirus vaccine requirement for all employers with more than 100 workers.

  • Fed reviews ethics policies after prolific trading uncovered
    startribune.com

    Fed reviews ethics policies after prolific trading uncovered

    The Federal Reserve is reviewing the ethics policies that govern the financial holdings and activities of its senior officials in the wake of recent disclosures that two regional Fed presidents engaged in extensive trading last year.

  • Federal Reserve reviews ethics policies after prolific trading uncovered
    investmentexecutive.com

    Federal Reserve reviews ethics policies after prolific trading uncovered

    Two regional Fed presidents traded excessively last year

  • Top Research Reports for NVIDIA, Johnson & Johnson & Toyota
    zacks.com

    Top Research Reports for NVIDIA, Johnson & Johnson & Toyota

    Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Johnson & Johnson (JNJ), and Toyota Motor Corporation (TM).

  • Bavarian Nordic A/S : Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial...
    marketscreener.com

    Bavarian Nordic A/S : Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

    COPENHAGEN, Denmark, September 16, 2021 – Bavarian Nordic A/S has today received information about the following transaction of the company's shares/related securities by persons… | September 16, 2021

  • Questex Announces Pandora as the Official Music Partner for Digital Pharma East and the 2021 Fierce Pharma Marketing Awards
    globenewswire.com

    Questex Announces Pandora as the Official Music Partner for Digital Pharma East and the 2021 Fierce Pharma Marketing Awards

    The Happy Fits to play a special concert honoring the Awards finalists NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) — Today, Questex announces that…

  • Civil society groups write to govt, Johnson and Johnson on vax supply
    thehindubusinessline.com

    Civil society groups write to govt, Johnson and Johnson on vax supply

    Apprehend a South Africa-type situation could emerge in India

  • Another Anti-Vaccine Radio Host Is Killed By Covid—Adding To A Growing List
    forbes.com

    Another Anti-Vaccine Radio Host Is Killed By Covid—Adding To A Growing List

    At least five unvaccinated right-wing radio hosts have died from Covid-19 over the past six weeks.

  • Adobe Inc Ranked Among Today’s Top Buys As COVID-19 Concerns Continue To Circle
    forbes.com

    Adobe Inc Ranked Among Today’s Top Buys As COVID-19 Concerns Continue To Circle

    The S&P 500 posted its best day in two weeks as it tries to stage a rally. Make the most of this market with today's Top Buys from Q.ai's artificial intelligence.

  • This ETF Examines Track Record, Not Just Yield
    etfdb.com

    This ETF Examines Track Record, Not Just Yield

    Yield alone isn't enough, and having a track record can help sustain dividends over time. Enter the Vanguard Dividend Appreciation Index Fund ETF Shares…

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Johnson & Johnson Aktie

Das Unternehmen Johnson & Johnson aus USA beschäftigt 141.700 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Drogerie & Kosmetik, Biotechnologie, Pharma tätig.

Johnson & Johnson ist in ungefähr 18 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter UBS ETF (IE) Factor  MSCI USA  Quality  UCITS  ETF (hedged to CHF) A-acc gewichtet Johnson & Johnson mit 4,34% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Johnson & Johnson Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Johnson & Johnson am höchsten gewichtet ist Insgesamt in 18 ETFs enthalten

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect